Parikh Anand Kiran
President and CEO
Parikh Anand Kiran has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 24, 2026.
On the most recent filing, Parikh Anand Kiran is listed as President and CEO at Faeth Therapeutics, Inc. Inside the rolling window, Parikh Anand Kiran reported 1 open-market purchase totaling $55K in FTH and no open-market sales.
Companies traded
Other insiders at FTH
Insider Buying
$55K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Parikh Anand Kiran made?
Parikh Anand Kiran has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Parikh Anand Kiran trade?
Parikh Anand Kiran has filed SEC Form 4 disclosures for 1 company, including FTH.
When was Parikh Anand Kiran's most recent SEC Form 4 filing?
Parikh Anand Kiran's most recent SEC Form 4 filing on Tracefour is dated Jun 24, 2026.
What is Parikh Anand Kiran's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Parikh Anand Kiran is listed as President and CEO.
What is Parikh Anand Kiran's total buy and sell value in the current window?
Inside the rolling retention window, Parikh Anand Kiran bought $55K and sold $0 based on SEC Form 4 filings.
What was Parikh Anand Kiran's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,806 FTH shares on 2026-06-22, worth $55K, per SEC Form 4 filings.